Form 4: Pfizer Executive Michael McDermott Reports Share Withholding for Tax Obligations
SEC Form 4 Filing
Executive Vice President Michael McDermott of Pfizer Inc. reported the withholding of 3,220 common stock shares to cover tax obligations upon the vesting of restricted stock units.
Summary
- On February 26, 2025, Michael McDermott, an Executive Vice President at Pfizer Inc., reported a transaction involving the withholding of 3,220 shares of common stock.
- The shares were withheld to satisfy tax obligations related to the vesting of restricted stock units, including dividend equivalents.
- The transaction occurred at a price of $26.42 per share.
- Following the transaction, McDermott directly owns 73,994 shares of Pfizer common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies like Pfizer.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine adjustment of executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of stock withholding transaction and power of attorney signature. |
| 02/28/2025 | Date of signature by power of attorney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.